MedTrace Logo

Safety Observation on hESC Derived MSC Like Cell for the Meniscus Injury

NCT03839238 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2019-02-15

No results posted yet for this study

Summary

human embryonic stem cell derived mesenchymal stem cells like cell for the meniscus injury, and observe the safety of the cells for meniscus injury

Conditions

  • Meniscus Injury

Interventions

BIOLOGICAL

hESC derived MSC like cell

Different dosage of hESC derived MSC like cell for the meniscus injured patients

Sponsors & Collaborators

  • Chinese Academy of Sciences

    collaborator OTHER_GOV

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • Hong Chen, Doctor · Wuhan TongJi Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-04
Primary Completion
2020-06-30
Completion
2020-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03839238 on ClinicalTrials.gov